Augmedix Inc (NASDAQ: AUGX) open the trading on Wednesday, with a bit cautious approach as it glided -6.64% to $2.53, before settling in for the price of $2.71 at the close. Taking a more long-term approach, AUGX posted a 52-week range of $2.61-$6.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 33.97%. Meanwhile, its Annual Earning per share during the time was 62.58%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -13.64%. This publicly-traded company’s shares outstanding now amounts to $48.61 million, simultaneously with a float of $43.96 million. The organization now has a market capitalization sitting at $123.89 million. At the time of writing, stock’s 50-day Moving Average stood at $3.74, while the 200-day Moving Average is $4.66.
Augmedix Inc (AUGX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Health Information Services industry. Augmedix Inc’s current insider ownership accounts for 10.23%, in contrast to 74.98% institutional ownership. According to the most recent insider trade that took place on Apr 15 ’24, this organization’s CHIEF STRATEGY OFFICER sold 500 shares at the rate of 3.80, making the entire transaction reach 1,900 in total value, affecting insider ownership by 3,000. Preceding that transaction, on Apr 12 ’24, Company’s CHIEF STRATEGY OFFICER sold 19,544 for 3.82, making the whole transaction’s value amount to 74,590. This particular insider is now the holder of 3,000 in total.
Augmedix Inc (AUGX) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/31/2023 suggests? It has posted -0.14 earnings per share (EPS) beating the forecaster’s viewpoint (set at -0.15) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
Augmedix Inc’s EPS decrease for this current 12-month fiscal period is -13.64% and is forecasted to reach -0.34 in the upcoming year.
Augmedix Inc (NASDAQ: AUGX) Trading Performance Indicators
Let’s observe the current performance indicators for Augmedix Inc (AUGX). It’s Quick Ratio in the last reported quarter now stands at 2.41. The Stock has managed to achieve an average true range (ATR) of 0.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.76.
In the same vein, AUGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44, a figure that is expected to reach -0.13 in the next quarter, and analysts are predicting that it will be -0.34 at the market close of one year from today.
Technical Analysis of Augmedix Inc (AUGX)
[Augmedix Inc, AUGX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 14.40% While, its Average True Range was 0.23.
Raw Stochastic average of Augmedix Inc (AUGX) in the period of the previous 100 days is set at 0.80%, which indicates a major fall in contrast to 1.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 47.17% that was lower than 55.53% volatility it exhibited in the past 100-days period.
